Abstract

Despite extensive research conducted to increase protein production from Chinese hamster ovary (CHO) cells, cellular bottlenecks often remain, hindering high yields. In this study, a transcriptomic analysis led to the identification of 32 genes that are consistently upregulated in high producer clones and thus might mediate high productivity. Candidate genes were associated with functions such as signaling, protein folding, cytoskeleton organization, and cell survival. We focused on two engineering targets, Erp27, which binds unfolded proteins and the Erp57 disulfide isomerase in the endoplasmic reticulum, and Foxa1, a pioneering transcription factor involved in organ development. Erp27 moderate overexpression increased production of an easy‐to‐express antibody, whereas Erp27 and Erp57 co‐overexpression increased cell density, viability, and the yield of difficult‐to‐express proteins. Foxa1 overexpression increased cell density, cell viability, and easy‐ and difficult‐to‐express protein yields, whereas it decreased reactive oxygen species late in fed‐batch cultures. Foxa1 overexpression upregulated two other candidate genes that increased the production of difficult‐ and/or easy‐to‐express proteins, namely Ca3, involved in protecting cells from oxidative stress, and Tagap, involved in signaling and cytoskeleton remodeling. Overall, several genes allowing to overcome CHO cell bottlenecks were identified, including Foxa1, which mediated multiple favorable metabolic changes that improve therapeutic protein yields.

Highlights

  • Chinese hamster ovary (CHO) cells are currently the main host cell factory for the production of therapeutic proteins

  • Cell engineering has so far mainly focused on improving the time integral of viable cell concentration, by increasing the maximum viable cell density (VCD) and extending culture duration, as well as on increasing the specific productivity of CHO cells, as both parameters are determinant for the volumetric productivity of recombinant therapeutic proteins (Farrell et al, 2014; Kim et al, 2012)

  • Despite the fact that Erp27 is a redox‐inactive member of the protein disulfide isomerase (PDI) family, it is likely to participate in protein folding, as it selectively binds to unfolded proteins and interacts with the disulfide isomerase Erp57 (Alanen et al, 2006; Kober et al, 2013)

Read more

Summary

| INTRODUCTION

Chinese hamster ovary (CHO) cells are currently the main host cell factory for the production of therapeutic proteins. Cell engineering has so far mainly focused on improving the time integral of viable cell concentration, by increasing the maximum viable cell density (VCD) and extending culture duration, as well as on increasing the specific productivity of CHO cells, as both parameters are determinant for the volumetric productivity of recombinant therapeutic proteins (Farrell et al, 2014; Kim et al, 2012) This was notably achieved by modulating the expression of genes involved in various cellular functions such as apoptosis, metabolism, cell cycle, and secretion (Fischer, Handrick, & Otte, 2015). We report that the expression of specific combinations of these engineering target genes yields increased cell density, viability, and specific productivity in fed‐batch cultures, resulting in higher production of easy‐to‐express as well as difficult‐to‐express therapeutic proteins and decreased reactive oxygen species (ROS), providing novel avenues towards highly efficient therapeutic protein production

| MATERIALS AND METHODS
| RESULTS
Findings
CONFLICT OF INTERESTS
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call